Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11

British Journal of Cancer

Volumn 109, Issue 2, 2013, Pages 493-496

  Koopmans, A E ^a   Vaarwater, J ^a   Paridaens, D ^b   Naus, N C ^a   Kilic, E ^a   De Klein, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

Author keywords

GNA11; GNAQ; MAPK; oncogenic mutation; survival; uveal melanoma

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT 11; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT Q; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURVIVAL; CHOROID MELANOMA; CHROMOSOME 1P; CHROMOSOME 3; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME LOSS; CODON; DISEASE FREE SURVIVAL; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; ONCOGENES; SURVIVAL ANALYSIS; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84881098070     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.299     Document Type: Article

References (10)

1. Abdel-Rahman MH, Cebulla CM, Verma V, Christopher BN, Carson 3rd WE, Olencki T, Davidorf FH (2012) Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Exp Eye Res 100: 26-31.
2. Bauer J, Kilic E, Vaarwater J, Bastian BC, Garbe C, de Klein A (2009) Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer 101: 813-815.
3. Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE (2012) Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 18: 4345-4355.
4. Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A (2005) Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 46: 2253-2257.
5. Mitsiades N, Chew SA, He B, Riechardt AI, Karadedou T, Kotoula V, Poulaki V (2011) Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: Rationale for personalized therapy. Invest Ophthalmol Vis Sci 52: 7248-7255.
6. Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW (2008) Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 49: 5230-5234.
7. Van Raamsdonk CD, Barsh GS, Wakamatsu K, Ito S (2009) Independent regulation of hair and skin color by two G protein-coupled pathways. Pigment Cell Melanoma Res 22: 819-826.
8. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457: 599-602.
9. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363: 2191-2199.
10. von Euw E, Atefi M, Attar N, Chu C, Zachariah S, Burgess BL, Mok S, Ng C, Wong DJ, Chmielowski B, Lichter DI, Koya RC, McCannel TA, Izmailova E, Ribas A (2012) Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines. Mol Cancer 11: 22.